Sanofi Consumer Healthcare India Limited has announced its 3rd Annual General Meeting (AGM) will be held on Friday, June 26, 2026, at 3:00 P.M. IST through Video Conferencing / Other Audio Visual Means. The company proposes to declare a final dividend of ₹75 per equity share for the financial year ended December 31, 2025. The agenda for the AGM includes the adoption of the Annual Audited Standalone Financial Statements for the year ended December 31, 2025, along with the Board of Directors' and Auditors' reports. Additionally, Mr. Stanislas Camart is proposed for re-appointment as Director, and M/s. Price Waterhouse & Co Chartered Accountants LLP are proposed for appointment as Statutory Auditors for a term of five consecutive years, effective from the conclusion of the AGM. The company also plans to appoint M/s. Price Waterhouse & Co Chartered Accountants LLP to fill a casual vacancy as Statutory Auditors until the conclusion of the 3rd AGM, effective May 25, 2026. Furthermore, the remuneration of M/s. Kishore Bhatia & Associates as Cost Auditors for the financial year ending December 31, 2026, amounting to ₹315,000 plus applicable taxes, is proposed for ratification. The dividend, if approved, will be paid on July 9, 2026, to eligible shareholders.
